Autonomize AI, a pioneer in AI-driven healthcare solutions, announced that it raised $28 million in Series A funding, bringing total capital raised to $32 million to date. Valtruis, The Cigna Group Ventures, Tau Ventures, and other strategic investors led the round. Plus, Asset Management Ventures, ATX Venture Partners, and Capital Factory are some of the company’s existing investors who also participated.
How the funding will be used: The funding will be utilized to advance the company’s mission of reimagining healthcare operations with its Agentic AI Orchestration platform, enabling healthcare knowledge workers to focus on delivering better patient care by reducing the administrative burden that drives costs, clinician burnout, and fragmented experiences.
Differentiation from the competition: Autonomize AI stands apart with a platform purpose-built for the realities of healthcare. And its pre-trained, ready-to-deploy AI agents handle some of the industry’s most demanding workflows like care management, utilization management, and benefits checks to chart reviews. And these agents work together as intelligent Copilots in a coordinated, multi-agent system that understands real workflows, not just prompts. This isn’t generic Generative AI. It is a healthcare-native orchestration platform that already delivers real, measurable value at scale within Fortune 100 healthcare enterprises.
Transformative results: Autonomize AI has already achieved transformative results, including:
1.) 36,000 clinical hours saved per month that were spent on mundane administrative tasks;
2.) 100,000+ automated care plans created monthly to free up care providers and case managers for higher-value patient interactions; and
3.) Up to 50% faster decisions for patients in prior authorizations and claims.
Founders: Autonomize AI was founded in 2022 by Ganesh Padmanabhan and Kris Nair to make healthcare more accessible, efficient, and patient-centered through the use of AI. The company is one of the few that has seen strong traction in multiple segments of the healthcare and life sciences industries, delivering both patient impact and proven value at scale by solving real operational challenges.
KEY QUOTES:
“The current healthcare system is no longer suited for the way care is delivered today—and too often, patients and clinicians pay the price in delayed treatment, wasted time, and unnecessary friction. Automation alone is not the answer for healthcare, but accountable, human-centered AI augmentation is. This funding will help us scale our platform to solve some of the most frustrating, high-impact operational challenges in healthcare, while keeping patients and care outcomes at the center.”
Ganesh Padmanabhan, CEO of Autonomize AI
“There’s never been a more important time to apply AI in healthcare. Healthcare operators are ready, but they need partners who understand real workflows and can deliver results at scale. That takes more than technical talent — it requires deep knowledge of how care is delivered and paid for. Autonomize AI gets that. Their platform enables healthcare operators to quickly deploy and scale AI agents across high-impact use cases — and they’re already driving real results at some of the country’s largest healthcare organizations. We’re excited for the opportunity to partner with them.”
Mike Spadafore, Managing Director at Valtruis
“Autonomize AI’s vision for augmenting, not replacing, the people who power healthcare is one we share. We see tremendous potential in the company’s platform to drive scalable, responsible innovation in healthcare operations while ensuring patients and providers remain at the center of care.”
Craig Cimini, Head of The Cigna Group Ventures
